| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0003 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |